This HTML5 document contains 190 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n11	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n8	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0164247/price-of-originator/
n3	http://linked.opendata.cz/ontology/sukl/
n5	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0164247/reimbursement/
n12	http://linked.opendata.cz/resource/sukl/specialization-restriction/
n17	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0164247/
skos	http://www.w3.org/2004/02/skos/core#
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0164247/core-reimbursement/
n21	http://linked.opendata.cz/resource/sukl/indgroup/
n15	http://linked.opendata.cz/resource/sukl/packing/
n7	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0164247/price/
n19	http://linked.opendata.cz/resource/sukl/company/
n18	http://linked.opendata.cz/resource/sukl/active-ingredient/
n16	http://linked.opendata.cz/resource/sukl/specialization-restriction/http://linked.opendata.cz/ontology/odcs/tabular/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n14	http://linked.opendata.cz/resource/sukl/registration-state/
xsdh	http://www.w3.org/2001/XMLSchema#
n9	http://www.sukl.cz/modules/medication/
n13	http://linked.opendata.cz/resource/sukl/df/
n10	http://linked.opendata.cz/resource/atc/

Statements

Subject Item

n2:0164247

rdf:type

n3:MedicinalProductPackaging

dcterms:title

CEFTAZIDIM STRAGEN 2 G

skos:notation

0164247

n3:hasATCCode

n10:J01DD02

n3:hasActiveIngredient

n18:CEFTAZIDIMUM-PENTAHYDRICUM

n3:hasDefinedDailyDose

n17:ddd

n3:hasDosageForm

n13:PLV-SOL-INJ-INF

n3:hasPackagingSize

10X1

n3:hasPacking

n15:VIA

n3:hasRegistrationHolder

n19:HTKCZ

n3:hasRegistrationState

n14:R

n3:hasRouteOfAdministration

n11:INJ-INF

n3:hasStrength

2GM/LAH

n3:hasIndicationGroup

n21:15

n3:hasSpecializationRestriction

n12:ATB n16:blank-cell

n3:containsDefinedDailyDoses

5.0

n3:hasRegistrationCode

15/ 069/08-C

n3:hasTitleSupplement

INJ+INF PLV SOL 10X2G

n3:containsUsualTherapeuticalDailyDoses

5

n3:hasBreakMarketingDate

2014-07-31+02:00

n3:hasCoreReimbursementSpecification

n4:2013-12-01 n4:2014-01-01 n4:2013-10-01 n4:2013-11-01 n4:2014-04-01 n4:2014-05-01 n4:2014-02-01 n4:2014-03-01 n4:2014-07-01 n4:2014-07-03 n4:2014-06-01 n4:2014-06-13 n4:2014-10-01 n4:2014-10-02 n4:2014-08-01 n4:2014-09-01 n4:2014-12-01 n4:2015-01-01 n4:2014-11-01 n4:2014-11-19 n4:2015-03-01 n4:2015-04-01 n4:2015-01-13 n4:2015-02-01 n4:2015-06-01 n4:2015-07-01 n4:2015-04-02 n4:2015-05-01 n4:2015-07-02 n4:2013-01-05 n4:2013-02-01 n4:2013-01-01 n4:2013-05-01 n4:2013-06-01 n4:2013-03-01 n4:2013-04-01 n4:2013-08-03 n4:2013-09-01 n4:2013-07-01 n4:2013-08-01

n3:hasIndicationRestriction

P

n3:hasPriceOfOriginatorSpecification

n8:2013-01-05 n8:2013-02-01 n8:2013-01-01 n8:2015-03-01 n8:2015-04-01 n8:2015-01-13 n8:2015-02-01 n8:2014-12-01 n8:2015-01-01 n8:2014-11-01 n8:2014-11-19 n8:2014-10-01 n8:2014-10-02 n8:2014-08-01 n8:2014-09-01 n8:2014-07-01 n8:2014-07-03 n8:2014-06-01 n8:2014-06-13 n8:2014-04-01 n8:2014-05-01 n8:2014-02-01 n8:2014-03-01 n8:2013-12-01 n8:2014-01-01 n8:2013-10-01 n8:2013-11-01 n8:2013-08-03 n8:2013-09-01 n8:2013-07-01 n8:2013-08-01 n8:2013-05-01 n8:2013-06-01 n8:2013-03-01 n8:2013-04-01 n8:2015-07-02 n8:2015-06-01 n8:2015-07-01 n8:2015-04-02 n8:2015-05-01

n3:hasPriceSpecification

n7:2015-04-02 n7:2015-05-01 n7:2015-06-01 n7:2015-07-01 n7:2015-07-02 n7:2014-11-01 n7:2014-11-19 n7:2014-12-01 n7:2015-01-01 n7:2015-01-13 n7:2015-02-01 n7:2015-03-01 n7:2015-04-01 n7:2014-06-01 n7:2014-06-13 n7:2014-07-01 n7:2014-07-03 n7:2014-08-01 n7:2014-09-01 n7:2014-10-01 n7:2014-10-02 n7:2013-10-01 n7:2013-11-01 n7:2013-12-01 n7:2014-01-01 n7:2014-02-01 n7:2014-03-01 n7:2014-04-01 n7:2014-05-01 n7:2013-03-01 n7:2013-04-01 n7:2013-05-01 n7:2013-06-01 n7:2013-07-01 n7:2013-08-01 n7:2013-08-03 n7:2013-09-01 n7:2013-01-01 n7:2013-01-05 n7:2013-02-01

n3:hasReimbursementSpecification

n5:2013-12-01 n5:2014-01-01 n5:2013-10-01 n5:2013-11-01 n5:2014-04-01 n5:2014-05-01 n5:2014-02-01 n5:2014-03-01 n5:2013-05-01 n5:2013-06-01 n5:2013-03-01 n5:2013-04-01 n5:2013-08-03 n5:2013-09-01 n5:2013-07-01 n5:2013-08-01 n5:2013-01-05 n5:2013-02-01 n5:2013-01-01 n5:2015-06-01 n5:2015-07-01 n5:2015-04-02 n5:2015-05-01 n5:2015-07-02 n5:2014-12-01 n5:2015-01-01 n5:2014-11-01 n5:2014-11-19 n5:2015-03-01 n5:2015-04-01 n5:2015-01-13 n5:2015-02-01 n5:2014-07-01 n5:2014-07-03 n5:2014-06-01 n5:2014-06-13 n5:2014-10-01 n5:2014-10-02 n5:2014-08-01 n5:2014-09-01

n3:hasResumedMarketingDate

2010-11-08+01:00

n3:hasUsualTherapeuticalDailyDose

n17:utdd

n3:pilFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DPI51090.pdf%26type%3Dpil%26as%3Dceftazidim-stragen-2-g-pil

n3:pilUri

n9:download.php?file=PI51090.pdf&type=pil&as=ceftazidim-stragen-2-g-pil

n3:spcFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC51091.pdf%26type%3Dspc%26as%3Dceftazidim-stragen-2-g-spc

n3:spcUri

n9:download.php?file=SPC51091.pdf&type=spc&as=ceftazidim-stragen-2-g-spc

n3:textOnTheWrapFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DOBAL51092.pdf%26type%3Dobal%26as%3Dceftazidim-stragen-2-g-obal

n3:textOnTheWrapUri

n9:download.php?file=OBAL51092.pdf&type=obal&as=ceftazidim-stragen-2-g-obal